Clark Estates Inc. NY Lowers Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

Clark Estates Inc. NY trimmed its holdings in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 27.6% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 239,630 shares of the company's stock after selling 91,497 shares during the quarter. Clark Estates Inc. NY owned about 0.22% of Definitive Healthcare worth $693,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Bayesian Capital Management LP bought a new stake in Definitive Healthcare during the 4th quarter worth about $41,000. KLP Kapitalforvaltning AS acquired a new stake in shares of Definitive Healthcare during the 4th quarter worth approximately $54,000. Two Sigma Securities LLC bought a new stake in shares of Definitive Healthcare during the fourth quarter worth approximately $56,000. Cerity Partners LLC acquired a new position in Definitive Healthcare in the first quarter valued at approximately $56,000. Finally, ProShare Advisors LLC lifted its holdings in Definitive Healthcare by 49.1% in the fourth quarter. ProShare Advisors LLC now owns 15,018 shares of the company's stock valued at $62,000 after buying an additional 4,943 shares during the period. 98.67% of the stock is owned by institutional investors.

Definitive Healthcare Trading Down 4.1%

Shares of DH stock traded down $0.16 during mid-day trading on Friday, reaching $3.74. 511,948 shares of the stock traded hands, compared to its average volume of 390,370. The stock's fifty day simple moving average is $3.83 and its two-hundred day simple moving average is $3.63. The company has a market cap of $555.91 million, a price-to-earnings ratio of -0.85, a price-to-earnings-growth ratio of 6.56 and a beta of 1.64. Definitive Healthcare Corp. has a 1-year low of $2.15 and a 1-year high of $5.68. The company has a quick ratio of 1.75, a current ratio of 1.75 and a debt-to-equity ratio of 0.37.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.02 by $0.03. The business had revenue of $59.19 million for the quarter, compared to analysts' expectations of $56.20 million. Definitive Healthcare had a positive return on equity of 3.69% and a negative net margin of 206.05%. The firm's revenue was down 6.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.08 earnings per share. On average, research analysts anticipate that Definitive Healthcare Corp. will post 0.16 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on DH shares. The Goldman Sachs Group increased their price objective on shares of Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a research report on Monday, May 12th. BTIG Research lowered Definitive Healthcare from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Finally, Wall Street Zen raised Definitive Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, June 21st. One analyst has rated the stock with a sell rating, seven have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $4.77.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.